Clinical Trials Directory

Trials / Completed

CompletedNCT01137188

Effect of Weight Loss on Psoriasis

Effect of Weight Loss on Skin Manifestations, Inflammatory Markers and Risk Factor for Comorbidity in Obese Patients With Psoriasis - a Randomized Cross-over Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University Hospital, Gentofte, Copenhagen · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Controlled data show that obesity is a risk factor for psoriasis and that psoriasis severity is correlated with the degree of overweight. No controlled interventional studies reporting on the effect of weight loss on psoriatic skin manifestations have been published and data from case reports are conflicting. Patients with psoriasis demonstrate an increased susceptibility to atherosclerotic comorbidities such as arterial hypertension, coronary vascular disease, stroke, hyperlipidemia and type II diabetes and in severe psoriasis there is an increased risk of early death. Lately the role of inflammation in the atherosclerotic process has been highlighted and the link between psoriasis and atherosclerosis may be explained by the concomitant systemic inflammation in psoriasis. Similarly a state of low level inflammation is seen in obesity where macrophages and adipocytes begin to show overlap in function and gene expression. This leads to an increased migration of macrophages into the adipose tissue and an increased secretion of pro-inflammatory cytokines. In summary, these data and theoretical considerations suggest that weight loss in obese patients with psoriasis may improve skin manifestations and reduce the risk of atherosclerotic comorbidity.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLow calorie dietLow calorie diet containing 800-1000 kcal/day

Timeline

Start date
2010-06-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2010-06-04
Last updated
2012-04-04

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01137188. Inclusion in this directory is not an endorsement.